Autopsy report · NCT04965753

FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Sponsor decision”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 2 years 4 months before it stopped.
55 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Foghorn Therapeutics Inc.
Sponsor type: Industry
Conditions: Advanced Synovial Sarcoma
Interventions: FHD-609
Participants: 55
Sites: 12
Countries: France, Italy, Spain, United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.